3 Year DFS vs. 5 Year OS as an endpoint for Adjuvant Colon Cancer Studies: Data from Randomized Trials
Disclosure
Suggestion
Methods
PPT Slide
Results
Conclusion (1)
Within study comparisons
Conclusion (2)
Discussion
Future work
Home Page: http://www.fda.gov/cder/drug/cancer_endpoints/default.htm
Download presentation source